9th Annual Live Medical Crossfire®: Hematologic Malignancies

Welcome and Introductions

Breakfast and Non-CE Product Theater: Rethinking BTK Inhibition in Previously Treated CLL/SLL and MCL

Keynote: Should We Treat Smoldering Multiple Myeloma Now?Experts Debate Treating High-Risk Patients